Stock

Spotify is increasing U.S. prices for many of its subscription plans

Spotify is increasing its prices in the United States for many of its subscription plans.

In a statement on its website, the audio streaming service said the increases were necessary so that it can ‘invest in and innovate on our product features and bring users the best experience.’

Here are the changes:

The company still offers a limited-service ad-supported tier, as well as a $5.99 plan for students. That price is not changing.

It’s only the second time Spotify has raised U.S. prices. The company is now consistently profitable, CEO Daniel Ek said during its latest earnings announcement, although its most recent monthly active user growth figure narrowly missed targets.

In April, Bloomberg News reported that price increases were coming in part to cover the cost of audiobooks, a service Spotify is trying to boost in part to reduce its reliance on music — royalty payments for which still comprise the largest part of its budget.

The increases come as some U.S. companies are announcing price cuts amid signs that consumer spending is flagging.

“Slower labor market momentum will continue to limit income growth and push more families to exercise spending restraint amid reduced savings buffers and higher debt burdens,” Gregory Daco, EY-Parthenon’s chief economist, said in a note Friday. “Factoring increased price sensitivity, household spending momentum will gradually cool.”

This post appeared first on NBC NEWS

You May Also Like

Investing

2023 was a relatively lackluster year, silver largely traded on volatility between US$22 and US$25 per ounce. The white metal started 2024 with less...

Latest News

Dong’s experience, both as head of the People’s Liberation Army Navy (PLAN) as well as operational assignments in the Chinese military’s Eastern and Southern...

Investing

The US was one of the world’s top silver producers in 2023, recording output of 1,000 metric tons (MT). While that’s far below first-place...

Investing

The Canadian pharmaceutical market is the eighth largest in the world and accounts for 2.2 percent of the global prescription drug market. But what...

Disclaimer: GreatWallStreetPublisher.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 GreatWallStreetPublisher.com

Exit mobile version